How Is The Market Feeling About Halozyme Therapeutics? - Halozyme Therapeutics ( NASDAQ:HALO )

4 weeks ago

Halozyme Therapeutics's HALO short percent of float has risen 3.46% since its last report. The company recently reported that it has 8.95 million shares sold short, which is 9.57% of all regular shares that are available for trading.

Ticker	Sentiment	Impact
HALO	Neutral	21 %